Table 1: Characteristics and BIRADS score of the 38 selected patients with ultrasound and digital mammography findings classified as BIRADS 3, 4 or 5. DM microcalc: presence of suspicious microcalcifications on digital mammography; HISTO: histology; n/a: not available.
MX BIRADS |
US IRADS |
MRI BIRADS |
Histology |
MX micro |
US Size (mm) |
MRI 1° Lesion (mm) |
MRI 2° Lesion (mm) |
MRI 3° Lesion (mm) |
Histo 1° Lesion (mm) |
Histo 2° Lesion (mm) |
Histo 3° Lesion (mm) |
1 |
3 |
5 |
IDC + DCIS |
|
7 |
60 |
32 |
7 |
58 |
28 |
7 |
4 |
4 |
4 |
IDC |
|
15 |
50 |
|
|
50 |
|
|
3 |
1 |
4 |
Intracystic papillary cancer |
X |
no |
15 |
8 |
|
15 |
10 |
|
4 |
4 |
5 |
IDC |
X |
25 |
80 |
|
|
90 |
|
|
1 |
3 |
5 |
Intraductal papilloma |
|
7 |
9 |
|
|
10 |
|
|
5 |
3 |
5 |
ID + DCIS |
X |
15 |
40 |
18 |
15 |
40 |
20 |
15 |
1 |
3 |
4 |
Sclerosing adenosis |
|
6 |
10 |
|
|
10 |
|
|
4 |
3 |
4 |
Papillary carcinoma |
X |
13 |
13 |
|
|
15 |
|
|
n/a |
4 |
1 |
Follow up |
|
19 |
0 |
|
|
|
|
|
1 |
4 |
5 |
ILC |
|
20 |
30 |
|
|
28 |
|
|
0 |
4 |
2 |
Usual ductal hyperplasia |
|
12 |
13 |
|
|
13 |
|
|
4 |
1 |
5 |
DCIS |
X |
No |
25 |
16 |
9 |
22 |
15 |
7 |
3 |
3 |
5 |
Papillary carcinoma |
|
20 |
25 |
|
|
24 |
|
|
5 |
5 |
5 |
IDC |
|
25 |
25 |
|
|
25 |
|
|
5 |
5 |
5 |
IDC + DCIS |
X |
40 |
50 |
24 |
9 |
52 |
25 |
10 |
0 |
3 |
2 |
Follow-up |
|
10 |
15 |
|
|
|
|
|
n/a |
3 |
2 |
Follow-up |
|
10 |
13 |
|
|
|
|
|
5 |
5 |
5 |
IDC |
|
20 |
40 |
22 |
|
39 |
20 |
|
2 |
3 |
3 |
Papillomatosis |
|
15 |
12 |
|
|
15 |
|
|
4 |
1 |
5 |
DCIS |
X |
no |
35 |
|
|
35 |
|
|
3 |
3 |
4 |
Papillary carcinoma |
|
25 |
25 |
12 |
|
25 |
10 |
|
4 |
4 |
3 |
Follow-up |
|
13 |
15 |
|
|
|
|
|
n/a |
3 |
2 |
Sclerosing adenosis |
|
10 |
12 |
|
|
|
|
|
4 |
1 |
3 |
Follow-up |
X |
no |
8 |
|
|
|
|
|
n/a |
4 |
2 |
Follow-up |
|
18 |
20 |
|
|
|
|
|
n/a |
3 |
2 |
Follow-up |
|
15 |
10 |
|
|
|
|
|
5 |
5 |
5 |
Multicentric IDC |
|
12 |
35 |
26 |
10 |
30 |
30 |
10 |
n/a |
4 |
3 |
Benign phyllodes tumour |
|
40 |
40 |
|
|
43 |
|
|
n/a |
4 |
2 |
Granulomatous mastitis |
|
25 |
25 |
|
|
25 |
|
|
4 |
1 |
5 |
DCIS |
X |
0 |
30 |
|
|
38 |
|
|
4 |
4 |
3 |
Complex sclerosing lesion |
|
22 |
23 |
|
|
23 |
|
|
4 |
4 |
5 |
IDC + ILC |
|
22 |
35 |
|
|
38 |
|
|
n/a |
3 |
2 |
Follow-up |
|
7 |
7 |
|
|
|
|
|
3 |
1 |
3 |
Follow-up |
|
no |
10 |
6 |
|
|
|
|
3 |
3 |
3 |
Papilloma |
|
5 |
5 |
|
|
5 |
|
|
n/a |
3 |
4 |
IDC |
|
15 |
10 |
|
|
11 |
|
|
0 |
3 |
4 |
IDC |
|
21 |
45 |
23 |
|
45 |
24 |
|
n/a |
3 |
4 |
Papillomatosis |
|
6 |
8 |
|
|
8 |
|
|